InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: Rdunn88 post# 252758

Thursday, 12/27/2018 4:54:38 PM

Thursday, December 27, 2018 4:54:38 PM

Post# of 402897
That is an absurd buyout valuation for Brilacidin. I have no doubt that B-ABSSSI alone can be sold for much more than $0.50 per share.

OM and IBD are very high potential indications with very low chance of failure due to adverse events. I am betting there are buyout offers available...they may be lower than what management will accept but are higher than the $0.50 you suggest.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News